Andy Lundin, Author at Advanced Oncology

Cutting-Edge Cancer Therapies: New Molecularly Targeted Agents

Posted by Andy Lundin | May 23, 2024 | Targeted Therapy |

Advancements in molecularly targeted agents are reshaping the landscape of oncology, providing hope for patients with various cancer types.

Posted by Andy Lundin | May 23, 2024 | Targeted Therapy |

Drug resistance in cancer treatment is being addressed with molecularly targeted agents, combination therapies, and personalized medicine.

Posted by Andy Lundin | May 23, 2024 | Immunotherapy |

One of the most promising advancements in the landscape of cancer treatment is the development of novel checkpoint inhibitors.

Posted by Andy Lundin | May 23, 2024 | Immunotherapy |

Breakthroughs in CAR-NK cell therapy for solid tumors, including clinical trials and innovative strategies to overcome challenges.

Posted by Andy Lundin | May 23, 2024 | Immunotherapy |

The latest advancements and clinical trials in CAR-T cell therapy for solid tumors, and new strategies in supporting cancer treatment.